Mistletoe vs. chemo: bladder cancer trial halted early

NCT ID NCT02106572

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if a mistletoe extract placed directly into the bladder could delay cancer return better than standard chemotherapy in 174 people with early-stage bladder cancer. The trial was stopped early, so results are limited. The approach focuses on controlling the disease rather than curing it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUPERFICIAL BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Non-Muscle Invasive Bladder Neoplasms superficial urinary bladder carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinic of Urology of the University Hospital of Essen

    Essen, 45122, Germany

  • Theodor Bilharz Research Institute

    Giza, 12411, Egypt

  • Urologische Facharztpraxis

    Würselen, 52146, Germany

  • Urologische Gemeinschaftspraxis

    Heinsberg, 52525, Germany

  • Urologische Praxis

    Herzberg, 37412, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.